A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial

Authors

Sube Banerjee
Nicolas Farina, Peninsula Medical School
Catherine Henderson, The London School of Economics and Political Science
Juliet High, University of East Anglia
Susan Stirling, University of East Anglia
Lee Shepstone, University of East Anglia
Julia Fountain, Sussex Partnership NHS Foundation Trust
Clive Ballard, University of Exeter
Peter Bentham, Birmingham and Solihull Mental Health NHS Foundation Trust
Alistair Burns, University of Manchester
Chris Fox, University of East Anglia
Paul Francis, University of Exeter
Robert Howard, University College London
Martin Knapp, The London School of Economics and Political Science
Iracema Leroi, Trinity College Dublin
Gill Livingston, University College London
Ramin Nilforooshan, Surrey and Borders Partnership NHS Foundation Trust
Shirley Nurock, Alzheimer's Society
John O’brien, University of Cambridge
Annabel Price, Cambridgeshire and Peterborough NHS Foundation Trust
Alan J. Thomas, Newcastle University
Ann Marie Swart, University of East Anglia
Tanya Telling, University of Sussex
Naji Tabet, University of Sussex

ORCID

• Sube Banerjee: 0000-0002-8083-7649
• Nicolas Farina: 0000-0002-0635-2547

DOI

10.3310/vpdt7105

Publication Date

2023-01-01

Embargo Period

2024-05-09

Recommended Citation

Banerjee, S., Farina, N., Henderson, C., High, J., Stirling, S., Shepstone, L., Fountain, J., Ballard, C., Bentham, P., Burns, A., Fox, C., Francis, P., Howard, R., Knapp, M., Leroi, I., Livingston, G., Nilforooshan, R., Nurock, S., O’brien, J., Price, A., Thomas, A., Swart, A., Telling, T., & Tabet, N. (2023) 'A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial', Available at: 10.3310/vpdt7105